BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25830652)

  • 1. Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.
    Gray ES; Reid AL; Bowyer S; Calapre L; Siew K; Pearce R; Cowell L; Frank MH; Millward M; Ziman M
    J Invest Dermatol; 2015 Aug; 135(8):2040-2048. PubMed ID: 25830652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
    Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
    J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterising the phenotypic evolution of circulating tumour cells during treatment.
    Tsao SC; Wang J; Wang Y; Behren A; Cebon J; Trau M
    Nat Commun; 2018 Apr; 9(1):1482. PubMed ID: 29662054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.
    Kupas V; Weishaupt C; Siepmann D; Kaserer ML; Eickelmann M; Metze D; Luger TA; Beissert S; Loser K
    J Invest Dermatol; 2011 Apr; 131(4):944-55. PubMed ID: 21270824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
    Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
    J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.
    Klinac D; Gray ES; Freeman JB; Reid A; Bowyer S; Millward M; Ziman M
    BMC Cancer; 2014 Jun; 14():423. PubMed ID: 24915896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating melanoma cells as a predictive biomarker.
    Karakousis G; Yang R; Xu X
    J Invest Dermatol; 2013 Jun; 133(6):1460-2. PubMed ID: 23673501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
    Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
    Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
    Lucci A; Hall CS; Patel SP; Narendran B; Bauldry JB; Royal RE; Karhade M; Upshaw JR; Wargo JA; Glitza IC; Wong MKK; Amaria RN; Tawbi HA; Diab A; Davies MA; Gershenwald JE; Lee JE; Hwu P; Ross MI
    Clin Cancer Res; 2020 Apr; 26(8):1886-1895. PubMed ID: 32015020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
    Lin SY; Chang SC; Lam S; Irene Ramos R; Tran K; Ohe S; Salomon MP; Bhagat AAS; Teck Lim C; Fischer TD; Foshag LJ; Boley CL; O'Day SJ; Hoon DSB
    Clin Chem; 2020 Jan; 66(1):169-177. PubMed ID: 31672856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma.
    Abusaif S; Jradi Z; Held L; Pflugfelder A; Weide B; Meier F; Garbe C; Eigentler TK
    Melanoma Res; 2013 Oct; 23(5):396-401. PubMed ID: 23907232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor Cells in Stage IV Melanoma Patients.
    Hall CS; Ross M; Bowman Bauldry JB; Upshaw J; Karhade MG; Royal R; Patel S; Lucci A
    J Am Coll Surg; 2018 Jul; 227(1):116-124. PubMed ID: 29746918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in melanoma patients.
    Clawson GA; Kimchi E; Patrick SD; Xin P; Harouaka R; Zheng S; Berg A; Schell T; Staveley-O'Carroll KF; Neves RI; Mosca PJ; Thiboutot D
    PLoS One; 2012; 7(7):e41052. PubMed ID: 22829910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
    Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS
    Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China.
    Li J; Fu W; Zhang W; Li P
    Med Sci Monit; 2018 Jan; 24():324-331. PubMed ID: 29337932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
    Koyanagi K; O'Day SJ; Boasberg P; Atkins MB; Wang HJ; Gonzalez R; Lewis K; Thompson JA; Anderson CM; Lutzky J; Amatruda TT; Hersh E; Richards J; Weber JS; Hoon DS
    Clin Cancer Res; 2010 Apr; 16(8):2402-8. PubMed ID: 20371696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.